25.47
Overview
News
Price History
Option Chain
Why PHG Down?
Discussions
Forecast
Stock Split
Dividend History
Koninklijke Philips N V Adr stock is traded at $25.47, with a volume of 1.01M.
It is up +0.08% in the last 24 hours and down -4.71% over the past month.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.
See More
Previous Close:
$25.45
Open:
$25.75
24h Volume:
1.01M
Relative Volume:
1.42
Market Cap:
$23.54B
Revenue:
$19.56B
Net Income/Loss:
$-358.43M
P/E Ratio:
-70.15
EPS:
-0.3631
Net Cash Flow:
-
1W Performance:
-3.12%
1M Performance:
-4.71%
6M Performance:
-17.71%
1Y Performance:
+32.43%
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Name
Koninklijke Philips N V Adr
Sector
Industry
Phone
-
Address
-
Compare PHG with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PHG
Koninklijke Philips N V Adr
|
25.47 | 23.54B | 19.56B | -358.43M | 0 | -0.3631 |
![]()
ABT
Abbott Laboratories
|
125.60 | 217.83B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
103.08 | 152.46B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
372.87 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.59 | 115.57B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.24 | 41.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-25-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Feb-20-25 | Upgrade | UBS | Neutral → Buy |
Oct-29-24 | Upgrade | Jefferies | Underperform → Hold |
May-13-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
May-07-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Apr-30-24 | Upgrade | JP Morgan | Underweight → Neutral |
Apr-30-24 | Upgrade | UBS | Sell → Neutral |
Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
Jul-12-23 | Initiated | Goldman | Buy |
Jan-17-23 | Downgrade | UBS | Neutral → Sell |
Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
Oct-14-22 | Downgrade | Deutsche Bank | Hold → Sell |
Sep-12-22 | Upgrade | Societe Generale | Hold → Buy |
Sep-06-22 | Upgrade | UBS | Sell → Neutral |
Jul-25-22 | Downgrade | Societe Generale | Buy → Hold |
Jun-16-22 | Downgrade | UBS | Neutral → Sell |
Jan-20-22 | Downgrade | Jefferies | Buy → Hold |
Jan-14-22 | Upgrade | HSBC Securities | Hold → Buy |
Jan-12-22 | Downgrade | Citigroup | Buy → Neutral |
Sep-08-21 | Initiated | Jefferies | Buy |
Jul-08-21 | Downgrade | Deutsche Bank | Buy → Hold |
Jun-21-21 | Downgrade | HSBC Securities | Buy → Hold |
Mar-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
Jul-28-20 | Initiated | Societe Generale | Buy |
Jul-30-19 | Initiated | Citigroup | Buy |
Feb-12-18 | Upgrade | Berenberg | Hold → Buy |
Nov-09-17 | Downgrade | JP Morgan | Overweight → Neutral |
Oct-16-17 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
Jun-21-17 | Downgrade | Natixis Bleichroeder | Buy → Neutral |
Apr-25-17 | Downgrade | Societe Generale | Buy → Hold |
Dec-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-23-16 | Initiated | Citigroup | Buy |
May-11-16 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Mar-01-16 | Upgrade | HSBC Securities | Reduce → Hold |
Feb-16-16 | Downgrade | Jefferies | Hold → Underperform |
Nov-27-15 | Initiated | ING Group | Hold |
Sep-08-15 | Initiated | Credit Suisse | Outperform |
Aug-27-15 | Upgrade | Nomura | Neutral → Buy |
Jul-28-15 | Upgrade | Societe Generale | Hold → Buy |
Jan-25-11 | Downgrade | HSBC Securities | Overweight → Neutral |
Dec-07-09 | Upgrade | Deutsche Bank | Hold → Buy |
Oct-16-09 | Upgrade | HSBC Securities | Neutral → Overweight |
May-08-09 | Downgrade | UBS | Buy → Neutral |
View All
Koninklijke Philips N V Adr Stock (PHG) Latest News
Urology Ultrasound Devices Market Report 2025-2030, By Type (Handheld, Compact), Application (Diagnosis, Treatment Planning), Disease, End-use, Region and Segment Forecasts - GlobeNewswire Inc.
Selling Your Koninklijke Philips N.V. ADR (PHG) Stock? Here’s What You Need To Know - Stocks Register
Data-Based Insights About Koninklijke Philips N.V. ADR (PHG) - Stocks Register
Koninklijke Philips N.V. ADR (PHG) Shares Up Despite Recent Market Volatility - The News Heater
P3 Health Partners Inc (PIII) Stock: Evaluating the Annual Growth - The News Heater
Nabors Industries Ltd (NBR) Stock: A SWOT Analysis - The News Heater
Sun Country Airlines Holdings Inc (SNCY) Stock: A Value Analysis - The News Heater
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
Weekly Upgrades and Downgrades - InvestorPlace
Europe Cancer Diagnostics Market Size & Outlook, 2024-2030 - Grand View Research
Picture Archiving and Communication System Patent Landscape Report, 2024-2032 - GlobeNewswire Inc.
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Validea Kenneth Fisher Strategy Daily Upgrade Report10/29/2024 - Nasdaq
Latin America Household Cooking Appliance Market Size & Outlook, 2030 - Grand View Research
Philips has another Class I level ventilator recall - Mass Device
PHG vs. ESLOY: Which Stock Is the Better Value Option? - Yahoo Finance
South Africa Smart Home Appliances Market Size & Outlook, 2030 - Grand View Research
China Refurbished Medical Imaging Devices Market Size & Outlook, 2030 - Grand View Research
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
China Operating Room Equipment Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Doppler Ultrasound Market Size & Outlook, 2030 - Grand View Research
New 4-Star Stocks - Morningstar
Germany Diagnostic Imaging Market Size & Outlook, 2030 - Grand View Research
Saudi Arabia Pancreatic Cancer Diagnostic Market Size & Outlook, 2030 - Grand View Research
Philips to repurchase shares for up to $137.4M - Mass Device
Philips stock rises on Street-beating Q2 - Mass Device
Philips inks new multi-year patient monitoring collab - Mass Device
Philips wins FDA clearance for next-gen digital pathology system - Mass Device
GE HealthCare: Initiating Coverage With Wide Moat, Shares Look Attractive - Morningstar.ca
Koninklijke Philips N V Adr Stock (PHG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):